Wellgistics Health (NASDAQ:WGRX) Shares Down 6.1% – Here’s What Happened

Wellgistics Health, Inc. (NASDAQ:WGRXGet Free Report) shares were down 6.1% during trading on Friday . The stock traded as low as $0.47 and last traded at $0.48. Approximately 656,038 shares traded hands during trading, a decline of 47% from the average daily volume of 1,242,681 shares. The stock had previously closed at $0.51.

Wall Street Analyst Weigh In

Several research analysts have commented on WGRX shares. Weiss Ratings restated a “sell (e)” rating on shares of Wellgistics Health in a research report on Wednesday, October 8th. Wall Street Zen cut shares of Wellgistics Health from a “hold” rating to a “sell” rating in a research note on Saturday, September 13th. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat, the stock presently has a consensus rating of “Sell”.

Read Our Latest Stock Report on WGRX

Wellgistics Health Stock Down 6.1%

The company has a current ratio of 0.32, a quick ratio of 0.11 and a debt-to-equity ratio of 11.16. The firm has a 50 day simple moving average of $1.04.

Wellgistics Health (NASDAQ:WGRXGet Free Report) last issued its quarterly earnings data on Tuesday, August 19th. The company reported ($0.11) earnings per share for the quarter. The company had revenue of $7.79 million for the quarter.

Wellgistics Health Company Profile

(Get Free Report)

Founded in 2022, Wellgistics Health is a holding company for various existing and planned strategic businesses centered around pharmaceuticals and healthcare services. As a micro health ecosystem, our portfolio of companies consists of a pharmacy, wholesale operations, and a technology division with a novel platform for hub and clinical services.

Recommended Stories

Receive News & Ratings for Wellgistics Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Wellgistics Health and related companies with MarketBeat.com's FREE daily email newsletter.